Successful Combination of (Methoxydimethyl)methyl (MIP) and (2-Naphthyl)methyl (NAP) Ethers for the Synthesis of Arabinogalactan-Type Oligosaccharides

Magdolna Csávás; Anikó Borbás; László Szilágyi; András Lipták

doi:10.1055/s-2002-31893

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Synlett 2002(6): 0887-0890
DOI: 10.1055/s-2002-31893

LETTER

Successful Combination of (Methoxydimethyl)methyl (MIP) and (2-Naphthyl)methyl (NAP) Ethers for the Synthesis of Arabinogalactan-Type Oligosaccharides

Magdolna Csávás^a, Anikó Borbás^a, László Szilágyi^b, András Lipták*^a
^a Research Group for Carbohydrates of the Hungarian Academy of Sciences, 4010 Debrecen, P.O. Box 55, Hungary
^b Department of Organic Chemistry, University of Debrecen, 4010 Debrecen, P.O. Box 20, Hungary
Fax: +36(52)512913; e-Mail: liptaka@tigris.klte.hu;

Further Information

Publication History

Received 9 April 2002
Publication Date:
07 February 2007 (online)

Abstract
Full Text
References

Permissions and Reprints All articles of this category

Abstract

In order to characterise the presumed epitopes of arabinogalactans, isolated from the extract of the cell-cultured Echinacea purpurea, two oligosaccharides were synthesized. The whole synthetic route was based on the successful combination of the (methoxydimethyl)methyl (MIP) and the (2-naphthyl)methyl ether (NAP) protecting groups. A β-(1→6)-linked trigalactoside was prepared, which contained a NAP ether at position 2′.This protecting group was selectively removed using either DDQ or Pd-C/H₂ and the acceptor was ready for further glycosylation.We have used two arabinofuranosyl donor compounds: 2,3,5-tri-O-acetyl arabinofuranosyl trichloroacetimidate and a peracetylated α-(1→5)-linked diarabinofuranosyl trichloroacetimidate. For the deprotection of the tetra- and pentasaccharides a common procedure was used. All of the synthesized compounds were characterized by ¹H and ¹³C NMR spectroscopy, as well as by MALDI-TOF mass-spectrometry.

Key words

arabinogalactan - oligosaccharides - protecting groups - (methoxydimethyl)methyl ether (MIP) - (2-naphthyl)methyl ether (NAP)

References

1 Hoson T. Int. Rev. Cytol. 1991, 130: 233

Google Scholar
2 Timmers CM. Wigchert SCM. Leeuwenburgh MA. van der Marel GA. van Boom JH. Eur. J. Org. Chem. 1998, 91

Crossref Google Scholar
3 Borbás A. Jánossy L. Lipták A. Carbohydr. Res. 1999, 318: 98

Crossref Google Scholar
4 Du Y. Pan Q. Kong F. Synlett 1999, 1648

Article in Thieme Connect Google Scholar
5 Du Y. Pan Q. Kong F. Carbohydr. Res. 2000, 323: 28

Google Scholar
6 Pan Q. Du Y. Kong F. Pan J. Lu M. J. Carbohydr. Chem. 2001, 20: 297

Crossref Google Scholar
7 Li B. Yu B. Hui Y. Li M. Han X. Fung KP. Carbohydr. Res. 2001, 331: 1

Crossref Google Scholar
8 Gu G. Yang F. Du Y. Kong F. Carbohydr. Res. 2001, 336: 99

Crossref Google Scholar
9 Csávás M. Borbás A. Jánossy L. Batta G. Lipták A. Carbohydr. Res. 2001, 336: 107

Crossref Google Scholar
10 Wagner H. Proksch A. Angew. Phytother. 1981, 2: 166

Google Scholar
11 Wagner H. Proksch A. Riess-Maurer I. Vollmar A. Odenthal S. Stuppner H. Jurcic K. Le Turdu M. Heur YH. Arzneim.- Forsch. 1984, 34: 659

Google Scholar
12 Proksch A. Wagner H. Phytochemistry 1987, 26: 1989

Crossref Google Scholar
13 Lipták A. Fügedi P. Kerékgyártó J. Nánási P. Carbohydr. Res. 1983, 113: 225

Crossref Google Scholar
14 Xia J. Abbas SA. Locke RD. Piskorz CF. Alderfer JL. Matta KL. Tetrahedron Lett. 2000, 41: 169

Crossref Google Scholar
15 Liao W. Locke RD. Matta KL. Chem. Commun. 2000, 369

Crossref Google Scholar
16 Lipták A. Borbás A. Jánossy L. Szilágyi L. Tetrahedron Lett. 2000, 41: 4949

Crossref Google Scholar
17 Gaunt MJ. Yu J. Spencer JB. J. Org. Chem. 1998, 63: 4172

Crossref Google Scholar

18

Spectroscopic data of compound 9: ¹H NMR (500 MHz, CDCl₃): δ 5.44 (d, 1 H, J _1,2 = 5.6 Hz, A-1), 4.26-4.28 (m, 1 H, A-2), 4.59 (dd, 1 H, J _2,3 = 7.9 Hz, J _3,4 = 2.3 Hz, A-3), 4.19 (dd, 1 H, J _4,5 = 1.9 Hz, A-4), 3.98-4.1 (m, 1 H, A-5), 4.15 (d, 1 H, J _5,6 = 8.6 Hz, A-6a), 3.58 (dd, 1 H, J _6a,6b = 10.3 Hz, A-6b), 4.26 (d, 1 H, J _1,2 = 5.2 Hz, B-1), 3.82 (dd, 1 H, J _2,3 = 8.3 Hz, B-2), 4.25 (s, 1 H, B-3), 4.07 (dd, 1 H, J _4,5 = 1.9 Hz, B-4), 3.94-3.96 (m, 1 H, B-5), 4.05 (dd, 1 H, J _5,6 = 2.3 Hz, J _6a,6a = 7.7 Hz, B-6a), 3.94-3.98 (m, 1 H, B-6b), 4.72 (d, 1 H, J _1,2 = 8.1 Hz, C-1), 5.23 (dd, 1 H, J _2,3 = 10.5 Hz, C-2), 5.01 (d, 1 H, J _3,4 = 3.4 Hz, C-3), 5.38 (dd, 1 H, J _4,5 = 0.9 Hz, C-4), 3.92-3.95 (m, 1 H, C-5), 4.15 (d, 2 H, J _6a,6b = 6.7 Hz, C-6a, C-6b), 5.45 (s, 1 H, d-1), 5.13 (s, 1 H, D-2), 4.99 (d, 1 H, J _3,4 = 3.7 Hz, D-3), 4.68 (dd, 1 H, J _4,5 = 7.1 Hz, D-4), 4.48 (dd, 1 H, J _5,6a = 3.4 Hz, J _6a,6b = 12.5 Hz, D-5a), 4.32 (dd, 1 H, J _5,6b = 2.5 Hz, D-5b), 1.25, 1.28, 1.38, 1.49, 1.52 (s, 24 H, 6 CH _3ip), 1.95, 2.02, 2.08, 2.01, 2.13, 2.15 (s, 21 H, 7 CH _3acetyl).
¹³C NMR (500 MHz, CDCl₃): 95.71 (A-1), 69.59 (A-2), 70.47 (A-3), 71.16 (A-4), 66.80 (A-5), 69.40 (A-6), 100.78 (B-1), 73.94 (B-2), 79.55 (B-3), 73.46 (B-4), 70.36 (B-5), 68.38 (B-6), 101.02 (C-1), 68.46 (C-2), 70.44 (C-3), 66.74 (C-4), 72.85 (C-5), 60.88 (C-6), 103.07 (D-1), 80.52 (D-2), 76.62 (D-3), 80.49 (D-4), 63.58 (D-5), 20.28, 20.36, 20.51, 20.54, 20.68 (CH_3acetyl), 23.75, 24.51, 25.60, 25.69, 26.02, 27.71 (CH_3ip), 108.03, 108.55, 110.34 (C_quat).
[α]_D: -45.32 (c 0.26, CHCl₃). MALDI-TOF measurements: 1073.25 [M + Na]⁺

19

Spectroscopic data of compound 14: ¹H NMR (500 MHz, CDCl₃): δ 5.59 (s, 1 H, H-1), 5.32 (d, 1 H, J _2,3 = 2.16 Hz, H-2), 5.28 (dd, 1 H, J _3,4 = 6.5 Hz, H-3), 4.32-4.35 (m, 1 H, H-4), 3.95 (dd, 1 H, J _4,5a = 4.3 Hz, J _5a,5b = 12.9 Hz, H-5a), 3.75 (dd, 1 H, J _4,5b = 3.8 Hz, H-5b), 5.14 (s, 1 H, H-1′), 5.16 (s, 1 H, H-2′), 4.94 (d, 1 H, J _3,4 = 4.3 Hz, H-3′), 4.26-4.30 (m, 1 H, H-4′), 4.45 (dd, 1 H, J _4,5a = 3.9 Hz, J _5a,5b = 12.9 Hz, H-5′a), 4.23 (dd, 1 H, J _4,5b = 4.7 Hz, H-5′b), 3.76 (s, 3 H, -OCH ₃), 2.09-2.18 (s, 15 H, CH _3acetyl), 6.78-7.02 (m, 4 H, -Ph). ¹³C NMR (500 MHz, CDCl₃): 104.49 (C-1), 81.74 (C-2), 76.04 (C-3), 81.38 (C-4), 64.87 (C-5), 105.18 (C-1′), 80.68 (C-2′), 76.96 (C-3′), 80.49 (C-4′), 62.96 (C-5′), 55.31 (-OCH₃), 20.30, 20. 43, 20.48 (CH_3acetyl), 169.11, 169.50, 169.85, 169.93, 170,26 (CH₃ CO-), 114.25, 117.97 (-Ph), 149.72, 154.89 (-Ph_quat).
[α]_D: -30.35 (c 0.32, CHCl₃). MALDI-TOF measurements: 621.51 [M + Na]⁺

20

Spectroscopic data of compound 17: ¹H NMR (500 MHz, CDCl₃): δ 5.42 (d, 1 H, J _1,2 = 5.2 Hz, A-1), 4.24-4.27 (m, 2 H, A-2, B-3), 4.56 (d, 1 H, J _3,4 = 2.3 Hz, A-3), 4.18 (dd, 1 H, J _4,5 = 8 Hz, A-4), 3.94-3.98 (m, 1 H, A-5), 3.58 (d, 1 H, A-6a), 4.13 (dd, 1 H, J _5,6b = 2.3 Hz, J _6a,6b = 10.3 Hz, A-6b), 4.26 (d, 1 H, J _1,2 = 8.5 Hz, B-1), 3.81 (dd, 1 H, J _2,3 = 6 Hz, B-2), 4.03 (dd, 1 H, J _3,4 = 1.8 Hz, B-4), 3.92-3.95 (m, 1 H, B-5), 3.92-3.96 (m, 1 H, B-6a), 4.03-4.06 (m, 1 H, B-6b), 4.69 (d, 1 H, J _1,2 = 8 Hz, C-1), 5.22 (dd, 1 H, J _2,3 = 10 Hz, C-2), 4.98 (dd, 1 H, J _3,4 = 3.5 Hz, C-3), 5.36 (dd, 1 H, J _4,5 = 1.1 Hz, C-4), 3.89-3.93 (m, 1 H, C-5), 4.13-4.16 (m, 2 H, C-6a, C-6b), 4.17 (s, 1 H, D-1), 5.08 (s, 1 H, D-2), 5.15 (d, 1 H, J _3,4 = 1.6 Hz, D-3), 4.56-4.5 (m, 1 H, D-4), 4.14 (d, 1 H, J _4,5a = 1.1 Hz, D-5a), 3.58 (dd, 1 H, J _4,5ab = 1.6 Hz, J _5a,5b = 9.8 Hz, d-5b), 5.46 (s, 1 H, E-1), 5.18 (s, 1 H, E-2), 4.91 (dd, 1 H, J = 4.9 Hz, J = 0.8 Hz, E-3), 4.29-4.34 (m, 1 H, E-4), 4.44 (dd, 1 H, J _4,5a = 3.1 Hz, J _5a,5b = 11.8 Hz, E-5a), 4.21-4.24 (m, 1 H, E-5b), 1.26, 1.30, 1.31, 1.36, 1.49, 1.53 (s, 24 H, CH _3ip), 1.95, 2.04, 2.06, 2.07, 2.08, 2.09, 2.10, 2.12, 2.15 (CH _3acetyl).
¹³C NMR (200 MHz, CDCl₃): 96.00 (A-1), 69.91 (A-2), 70.74 (A-3), 71.40 (A-4), 67.04 (A-5), 69.55 (A-6), 101.07 (B-1), 74.08 (B-2), 79.84 (B-3), 73.75 (B-4), 70.74 (B-5), 68.62 (B-6), 101.30 (C-1), 68.75 (C-2), 70.74 (C-3), 67.04 (C-4), 70.74 (C-5), 61.13 (C-6), 104.91 (D-1), 80.84 (D-2), 77.63 (D-3), 80.98 (D-4), 63.35 (D-5), 104.91 (E-1), 81.34 (E-2), 76.13 (E-3), 81.84 (E-4), 64.87 (E-5), 20.58, 20.75 (CH_3acetyl), 24.08, 24.73, 25.87, 26.00, 26.29, 27.94, 29.19, 30.83 (CH_3ip), 108.12, 108.85, 110.57 (C_quat), 169.27, 169.35, 169.80, 169.88, 170.15, 170.27, 170.36, 170.48 (CH₃ CO).
[α]_D: -66.18 (c 0.3173, CHCl₃). MALDI-TOF measurements: 1289.87 [M + Na]⁺

21

Spectroscopic data of compound 1: ¹H NMR (500 MHz, D₂O): δ 5.21 (A-1α, J _1,2 = 3.8 Hz), 4.53 (A-1β, J _1,2 = 7.9 Hz), 3.41 (A-2β), 3.60 (A-3β), 4.49 (B-1, J _1,2 = 7.8 Hz), 3.58 (B-2), 3.72 (B-3), 4.40 (C-1, J _1,2 = 7.8 Hz), 3.44 (C-2), 3.60 (C-3), 5.24 (D-1, J _1,2 = 3.7 Hz), 4.12 (D-2), 3.90 (D-3), 4.17 (D-4), 3.67 and 3.75 (D-5a and d-5b).¹³C NMR (500 MHz, H₂O): 92.07 (A-1α), 96.09 (A-1ι), 71.52 (A-2ι), 72.39 (A-3β), 69.16 (A-6β), 101.61 (B-1), 75.66 (B-2), 72.49 (B-3), 68.73 (B-6), 103.07 (C-1), 70.43 (C-2), 72.41 (C-3), 60.69 (C-6), 107.93 (D-1), 80.64 (D-2), 76.57 (D-3), 83.95 (D-4), 61.07 (D-5).
[α]_D: -1.55 (c 0.1931, H₂O).MALDI-TOF measurements: 657.14 [M + Na]⁺

22

Spectroscopic data of compound 2: ¹H NMR (500 MHz, D₂O): δ 5.20 (A-1α, J _1,2 = 3.98 Hz,), 4.52 (A-1β, J _1,2 = 8.16 Hz), 3.72 (A-2α), 3.44 (A-2ι), 3.59 (A-3), 3.91 (A-4), 4.48 (B-1, J _1,2 = 8.16 Hz), 3.59 (B-2), 3.71 (B-3), 3.91 (B-4), 4.40 (C-1, J _1,2 = 8.16 Hz), 3.48 (C-2), 3.59 (C-3), 3.87 (C-4), 5.03 (D-1, J _1,2 = 2.39 Hz,), 4.08 (D-2), 5.23 (E-1), 4.12 (E-2).
¹³C NMR (500 MHz, H₂O): 92.08 (A-1α), 96.10 (A-1β), 71.55 (A-2), 72.41 (A-3), 60.69 (A-6), 101.69 (B-1), 75.60 (B-2), 74.85 (B-3), 102.84 (C-1), 70.43 (C-2), 72.35 (C-3), 69.17 and 68.73 (B-6 and C-6), 107.10 (D-1), 80.60 (D-2), 76.24 (D-3), 82.25 (D-4), 66.55 (D-5), 107.98 (E-1), 80.60 (E-2), 76.90 (E-3), 83.63 (E-4), 60.89 (E-5).
MALDI-TOF measurements:791.13 [M + Na]⁺.